Breaking Consumers Receive Tariff Refunds as Shippers Pass Savings Forward Kennedy Center Board to Consider Venue Closure for Renovations Amidst Legal Challenges Southern California Beaches See Surge in Stingray Injuries Amid Marine Heat Wave Texas Judge Orders Life-Sustaining Care for Newborn Amid Surrogate Dispute Cabinet Members Depart NATO Summit on Decoy Flight Amid Iranian Threat

Thursday August 13, 2026

Reporter

Belite Bio, Inc

3Articles Published

4Communities Covered

Published Articles

Press Release

Belite Bio Reports Unaudited Second Quarter 2026 Financial Results and Provides a Corporate Update

3 hours ago

Press Release

Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1

Aug 11

Press Release

Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results

Aug 6